Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Deficiency on Cardiovascular Risk
NCT06369363Phase 1Not yet recruiting
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
Phase 1, randomised, double-blind trial of estradiol topical in postmenopause (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Red blood cell flux at 1 week, Mean arterial pressure at 1 week and 3 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
estradiol topical
03
Conditions
postmenopause
Beyond the preview
Go deeper on NCT06369363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369363.